Company / Tangible Book Value per Share
ImmunityBio, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
-$0.59
FY2025
5-year range
-$1.39 / -$0.59
FY2021-FY2025
Trend
+19.5%
vs FY2024
Sector context
#188 of 209
Health Care
What the data says
Among 209 Health Care companies, ImmunityBio, Inc. is in the bottom 10% for tangible book value per share. Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $-1.39 in FY2023 to $4.34 in FY2017.
Based on SEC 10-K filings.
-0.59 in FY2025.
Improved from $-1.39 to $-0.59 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 209This company -$0.59 Sector average $119.74
▼
-100.5% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 19.5% year-over-year.
- Ranks #188 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2017.
- Lowest tangible book value per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -7.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.59 | +19.5% |
| FY2024 | -$0.73 | +47.5% |
| FY2023 | -$1.39 | -23.8% |
| FY2022 | -$1.12 | -77.5% |
| FY2021 | -$0.63 | +47.9% |
| FY2020 | -$1.22 | -179.7% |
| FY2019 | $1.53 | -58.9% |
| FY2018 | $3.71 | -14.5% |
| FY2017 | $4.34 | +513.1% |
| FY2016 | $0.71 | -99.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026